Salute e Benessere

Leonard A. Lauder is honored with the Neiman Marcus Award for Distinguished…

"Leonard Lauder is a singular force who forever changed the beauty industry. His stewardship led The Estée Lauder Companies to become home to some of the world's most beloved beauty brands," said Geoffroy van Raemdonck, Chief Executive Officer, Neiman Marcus Group. "He understands the power of relationships and his values are imbued in everything the company stands for. Along every step of the way, he has been a remarkable partner in our journey to bring the world's most coveted…

Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major…

Bagsværd, Denmark, 21 October 2024— Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide to placebo as an adjunct to standard of care for the prevention of major adverse cardiovascular events (MACE). The trial enrolled 9,650 people with type 2 diabetes and established cardiovascular disease (CVD) and/or chronic kidney disease (CKD). As part of standard of care, 49% of patients received...

KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment

A First in the Middle East and North Africa RIYADH, Saudi Arabia, Oct.21, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched the first-of-its-kind Mobile Stroke Ambulance Unit in the Middle East and North Africa, bringing advanced medical technology and clinical expertise directly to stroke patients. This innovation allows the medical team to use travel time to provide immediate medical care, significantly improving recovery and...

Mediso introduces true theranostic TheraMAX SPECT/CT

The TheraMAX is equipped with three, large surface detectors (up to 5x larger than 12-detector CZT systems) surrounding the patients completely (360Â°). The 15.9mm thick NaI crystals ensure improved sensitivity for high energy photons, while the high-density sensor arrangement (123 PMT per detector head) allows high spatial resolution leading to PET-like image quality in all NM applications. The TheraMAX is equipped with three, large surface detectors (up to 5x larger than 12-detector CZT...

NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing…

At the heart of NIANCE's product development is its proprietary FERNESSE™ biotechnology, which maximizes the bioavailability of over 130 active ingredients used in the formulations. FERNESSE™ ensures that the body fully absorbs these powerful bioactive compounds, enhancing the efficacy of the products and ensuring deep cellular rejuvenation. At the heart of NIANCE's product development is its proprietary FERNESSE™ biotechnology, which maximizes the bioavailability of over 130 active…

Evosep Expanding Capabilities with New Headquarters to Support Rising Needs in…

To further support the seamless integration of its technologies into pharmaceutical and regulated laboratories, Evosep is releasing Installation Qualification (IQ) and Operational Qualification (OQ) protocols. These IQ/OQ service offerings are designed to ensure that Evosep's proteomics solutions meet the stringent quality and compliance standards required in regulated pharma environments. By providing comprehensive IQ/OQ services including innovative (patent-pending) OQ methodology and fully…

FRESHA INVESTS IN YUV TO REVOLUTIONIZE HAIR COLORING WITH CUTTING-EDGE…

Hair coloring is a complex service that requires precision and consistency. Yuv's technology allows salons to save personalized hair color formulas directly in customer profiles, ensuring a consistent and tailored experience for every client. For salon owners, this means they can offer a high-quality, customized service every time, which not only strengthens client loyalty and drives repeat business but also contributes to environmental sustainability. Hair coloring is a complex service that...

SciBase continues US expansion and will attend Fall Clinical conference

The new consensus report that was published in the JDD (September 2024 issue) will also be presented at the 44th annual Fall Clinical Dermatology Conference ("Fall Clinical 2024"). The consensus report evaluated several technologies for melanoma diagnosis and supports the use of Nevisense for its ability to significantly enhance clinician's diagnostic assessment of atypical moles by non-invasively providing them with critical information at point of care. The new consensus report that…

Press Release: Sanofi and CD&R partner to fuel Opella's ambitions in consumer…

Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journeySanofi to become a focused science-driven biopharma delivering innovative medicines and vaccines to patients Sanofi 2024 business EPS...

ONWARD® Medical Announces Changes to Board of Directors, Including Addition of…

Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech EuropeCommercial and digital health expert Rahma Samow will also join as DirectorCurrent Board Chairman Jan Ohrstrom and Director Fred Colen to retire from the Board at year-end after 8 years of service EINDHOVEN, the Netherlands, Oct.21, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation...

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to…

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-01 1, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseasesCureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of Korea, China, Hong Kong, Macau and TaiwanThe collaboration builds on Angelini Pharma's strong...

KFSHRC Leads the Way in AI-Powered Diagnostics and Minimally Invasive Surgeries

RIYADH, Saudi Arabia, Oct.20, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to contribute to advancing healthcare through pioneering advancements in AI-driven diagnostics and minimally invasive surgeries, advancing precision and outcomes while contributing to global innovation.At the core of these advancements is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed numerous AI applications and predictive models that...

Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+…

The Exhibition's sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors. The Exhibition's sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors. Experts will...

KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional…

RIYADH, Saudi Arabia, Oct.19, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer treatment in the region with transformative therapies like CAR-T cell therapy and CRISPR gene editing. With over 40 years of expertise, KFSHRC has emerged as a global leader in delivering breakthrough personalized cancer care.In 2023, the Oncology Centre of Excellence treated 25% of all cancer cases in Saudi Arabia, achieving an overall...

Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's…

Curio's MamaLift is a general wellness product that manages neurobehavioral symptoms during pregnancy and postpartum period. It empowers mothers to manage stress, anxiety, and other neurobehavioral symptoms by providing bite-sized digital doses of CBT, evidence-based self management tools, insightful trackers, and on-demand access to health coaches. Curio's "digital dose" approach uniquely ensures user-friendliness, requiring only 10 minutes of daily engagement. It caters to the busy…

Accord Healthcare receives positive CHMP opinion for IMULDOSA®, a ustekinumab…

Mr. Paul Tredwell, Executive Vice President of Accord Healthcare, said, "We are delighted with the positive CHMP opinion for Imuldosa®. This further strengthens our established autoimmune franchise, where Accord already has several leading speciality brands. The recommendation affirms Accord's continued strategy to expand its speciality business with an industry-leading portfolio, this positive opinion, combined with a further 10 biosimilars in development, reaffirms our commitment to…

Roche's Vabysmo improved vision in underrepresented populations with diabetic…

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema (DME) treated with Vabysmo who identify as African American, Black, Hispanic and Latino 1 Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies 1 These racial and ethnic groups aredisproportionately affected by diabetes and at higher risk of developing DME, a leading cause of vision...

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, October 24 – 28 th, 2024 in Boston, Massachusetts. This year's meeting will feature a “Product Theater” onWhat Defines an Optimal Peanut Allergy Treatment?...

RAMSAY SANTE :Annual results at the end of June 2024

PRESS RELEASE Paris, 18 thOctober 2024 Annual results at the end of June 2024As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its pioneering role in access to care and medical innovation benefiting 12.6 million patients in France, the 3 Nordics countries and Italy.Ramsay Santé has further implemented its “Yes We Care 2025” unique and differentiating strategy to offer integrated care to patients,...

Microfiber Cleaning Cloth Market Surges to USD 11043.79 Million by 2030…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=142099 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=142099 Browse in-depth TOC onMicrofiber Cleaning Cloth Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Microfiber Cleaning Cloth Market Overview Increasing Demand for Eco-friendly Cleaning Solutions The growing shift towards eco-friendly and sustainable cleaning...

Pain Management Devices Market to Hit USD 5,835.8 Million by 2029 with 9.1% CAGR…

Browse in-depth TOC on "Pain Management Devices Market" Browse in-depth TOC on "Pain Management Devices Market" 294 - Tables 64 - Figures 297 - Pages High procedural cost, and increasing product recalls are likely to hamper the growth of pain management devices market Based on type, the neurostimulation devices segment held the largest share of of the pain management devices market. Due to the large number of ongoing clinical studies to establish the efficacy and safety...

Cattle & Porcine/Swine Reproductive Diseases Market to Hit USD 975.8 Million by…

Browse in-depth TOC on "Cattle & Porcine/Swine Reproductive Diseases Market" Browse in-depth TOC on "Cattle & Porcine/Swine Reproductive Diseases Market" 335 - Tables 66 - Figures 333 - Pages In this report, the cattle & porcine/swine reproductive diseases market is segmented into product type, diseases type, animal type, end user type and region. Based on product type,the cattle & porcine/swine reproductive diseases market is divided into devices,...

Amorepacific Presents Latest Research at IFSCC

SEOUL, South Korea, Oct. 18, 2024 /PRNewswire/ -- Amorepacific presented its latest research at this year's International Federation of Societies of Cosmetic Chemists conference (34th Congress IFSCC BRAZIL) held in Foz do Iguaçu, Brazil, from October 14 to 17. SEOUL, South Korea , Oct. 18, 2024 /PRNewswire/ -- Amorepacific presented its latest research at this year's International Federation of Societies of Cosmetic Chemists conference (34th Congress IFSCCBRAZIL ) held in Foz do...

Endo Presents Data at the American Society of Podiatric Surgeons (ASPS) Annual…

"We're pleased to share data with healthcare providers about our plantar fibromatosis clinical trials to help improve patient care and discuss our clinical development program," said James P. Tursi, M.D., Executive Vice President, Global Research & Development at Endo. "These presentations also demonstrate our growth strategy to develop a musculoskeletal pipeline serving those suffering from this and other burdensome conditions." "We're pleased to share data with…

Altri Comunicati